Menu
Log in
Forgot password



Your Resource for Neurotherapeutics Discovery and Development


Log in

Submitting an Abstract

As the nation’s premier educational and scientific event for neurotherapeutics professionals, the ASENT Annual Meeting is the ideal venue to present neurotherapeutics research results to an audience of potential collaborators and investors.

Authors will have the opportunity to present their research live in Bethesda and have it cited in the high impact journal Neurotherapeutics after the meeting.

The ASENT Abstract Review Committee is committed to presenting the best in neurotherapeutic research at the ASENT Annual Meeting. All abstracts are evaluated by experts in neurotherapeutics according to the following criteria and overall merit:

  1. Scientific or clinical impact

  2. Quality of data, analysis, and presentation

  3. Relevance to the discovery and/or development of neurotherapeutics and inclusion of novel targets or new initiatives.

  4. Abstracts must be submitted, presented, and cited in English.


The abstract should describe original research broadly relevant to the goal of ASENT, which is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system. Please check your abstract carefully for typographical errors, misspellings, etc. Be sure to include data results.

Guidelines for Submission

  • ASENT welcomes Encore Abstracts, or those abstracts that have been previously presented at other recent scientific meetings, or submitted for consideration to other scientific meetings.

  • Trainees and early career researchers are encouraged to submit

  • All sectors (academic, industry, government, etc.) are welcome to submit

  • Trial Designs or Trials in Progress are welcome and considered 

  • Case Studies or Case Reports will not be considered

IF ACCEPTED: One presenting author must be designated to attend the Annual Meeting in person. All attendees must register to attend the meeting via asent.org separate from this form. 

Poster Presentations

If your abstract is selected for a poster, you will need to be available to participate in our poster presentation at the annual meeting. This is scheduled to take place on Wednesday, March 4, 2026 at 5pm.

Poster Size/Format

Each poster board is 4x8, as such the specs for printing are: 

  • Each poster will have a maximum display area of 4 feet high by 6 feet wide to display your materials.
  • SIZE: Your poster should be no larger than 4’ high x 6’ wide. 
  • Please use thin poster paper or laminated paper – nothing heavier will stay in position.

Oral Presentations

Submitted abstracts that most closely conform to the above criteria, and the ASENT goals, may also be selected for a 10-minute oral presentation (including 2 minute Q&A) at our Oral Presentation session. ASENT encourages abstracts from private, public and startup companies and government or academic labs that contain neurotherapeutic research results.

The ASENT Annual Meeting attracts a broad spectrum of researchers, clinicians, investors, and other leaders in neurotherapeutics from all over the world, in all neurologic disease states. Oral presentations increase exposure to strategic partners in life sciences who have supported novel approaches through partnerships or strategic investments.

Submission Details

Title

Enter the full title of your submission. This will be used for printing in the final program.

  • Title should be max 50 words

  • The title should be entered in mixed case (otherwise known as Sentence Case: do not use ALL CAPITAL LETTERS). 

  • Do not use formatting tags in the title (with the possible exception of the lowercase tag).

  • The title should use capital letters only where appropriate. 

  • Do not use abbreviations in the title unless they are universally understood in the field (e.g. EEG, MRI, PET Scan).

Abstract Body

Please enter the body of your abstract (max 500 words)

The body of the abstract should be one paragraph with no subheadings but organized as follows:

  • A sentence stating the study's purpose.

  • A brief description of methods.

  • A summary of the results.

  • A statement of conclusions reached. Do not simply state "the results will be discussed."

  • Do not include tables or graphs.

  • Do not include citations.

Use of both product and chemical names (capitalized) is acceptable
Abstracts must be submitted in English and all presentations will be in English.

Authors and Affiliations

You MUST enter the names of ALL authors here - including yourself if you are an author - in the order in which you wish them to appear in the printed text. Names omitted here will NOT be printed in the journal or the final program. 

  • Use Sentence Case. DO NOT USE ALL CAPS

Please enter all authors in the order they should appear in the heading of the abstract. The name of the lead author will appear in the first author position and marked as the presenter during poster or oral presentation.

Permission to Publish

Please select YES to give us permission to publish your submission.

All accepted abstracts will be published online in the journal, NEUROTHERAPEUTICS, the official journal of the American Society for Experimental Neurotherapeutics, and in the ASENT annual meeting program, unless the submitting author requests otherwise.

Presentation Format 

You will be asked to select the presentation format you wish to submit this abstract for consideration. Below you will find descriptions of each: 

Oral Presentation and Poster 

  • Oral presenters are given the opportunity to make a brief 6-10 minute presentation with 2-3 slides. Oral presentations will take place on Thursday, March 5, 2026. They are also asked to stand by their posters during the poster session and networking reception at the annual meeting, scheduled to take place on Wednesday, March 4 at 5:00pm.

Poster Presentation 

  • Poster presenters are asked to stand by their posters during the poster session and networking reception at the annual meeting, scheduled to take place on Wednesday, March 4 at 5:00pm.

Embargo Policy

  • Abstracts, not including late-breaking science abstracts, will be available mid February 2026.

  • Authors of abstracts featured in an ASENT press release must abide by our abstract guidelines and embargo dates. Authors will be notified at acceptance if their abstract has been selected for ASENT press release. Embargo dates for these abstracts will be communicated to the authors directly. Press releases will be distributed to credentialed journalists by late early February 2026.

Acceptance

ASENT will communicate solely with the first/presenting author if accepted. Please be sure the contact information is current. We utilize the Oxford Abstract submission system, as such you will be asked to create a profile. The ASENT Program Committee reserves the right to reject any abstract that has not complied with the aforementioned rules. Thank you for your participation.

For questions regarding abstracts, please email jessica@asent.org.

Powered by Wild Apricot Membership Software